Sorafenib and Bavituximab Plus SBRT in Unresectable Hepatocellular Carcinoma
Clinical trial NCT02989870 · WITHDRAWN
Trial details
- NCT number
- NCT02989870
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-27
- Primary completion
- 2018-10-15
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.